Literature DB >> 28964912

Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice.

Gwynne L Davis1, Adele Stewart2, Gregg D Stanwood3, Raajaram Gowrishankar4, Maureen K Hahn5, Randy D Blakely6.   

Abstract

Recent genetic analyses have provided evidence that clinical commonalities associated with different psychiatric diagnoses often have shared mechanistic underpinnings. The development of animal models expressing functional genetic variation attributed to multiple disorders offers a salient opportunity to capture molecular, circuit and behavioral alterations underlying this hypothesis. In keeping with studies suggesting dopaminergic contributions to attention-deficit hyperactivity disorder (ADHD), bipolar disorder (BPD) and autism spectrum disorder (ASD), subjects with these diagnoses have been found to express a rare, functional coding substitution in the dopamine (DA) transporter (DAT), Ala559Val. We developed DAT Val559 knock-in mice as a construct valid model of dopaminergic alterations that drive multiple clinical phenotypes, and here evaluate the impact of lifelong expression of the variant on impulsivity and motivation utilizing the 5- choice serial reaction time task (5-CSRTT) and Go/NoGo as well as tests of time estimation (peak interval analysis), reward salience (sucrose preference), and motivation (progressive ratio test). Our findings indicate that the DAT Val559 variant induces impulsivity behaviors that are dependent upon the reward context, with increased impulsive action observed when mice are required to delay responding for a reward, whereas mice are able to withhold responding if there is a probability of reward for a correct rejection. Utilizing peak interval and progressive ratio tests, we provide evidence that impulsivity is likely driven by an enhanced motivational phenotype that also may drive faster task acquisition in operant tasks. These data provide critical validation that DAT, and more generally, DA signaling perturbations can drive impulsivity that can manifest in specific contexts and not others, and may rely on motivational alterations, which may also drive increased maladaptive reward seeking.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attention-deficit hyperactivity disorder; Dopamine transporter; Impulsivity; Instrumental learning; Motivation; Transgenic model

Mesh:

Substances:

Year:  2017        PMID: 28964912      PMCID: PMC5645257          DOI: 10.1016/j.bbr.2017.09.043

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  76 in total

1.  DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Authors:  Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

Review 2.  The interaction between reinforcement and inhibitory control in ADHD: A review and research guidelines.

Authors:  Ili Ma; Anna van Duijvenvoorde; Anouk Scheres
Journal:  Clin Psychol Rev       Date:  2016-01-06

Review 3.  Attention-deficit hyperactivity disorder.

Authors:  Joseph Biederman; Stephen V Faraone
Journal:  Lancet       Date:  2005 Jul 16-22       Impact factor: 79.321

Review 4.  Strengths and limitations of genetic models of ADHD.

Authors:  Raul R Gainetdinov
Journal:  Atten Defic Hyperact Disord       Date:  2010-03-06

Review 5.  Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

Authors:  Michael A van der Kooij; Jeffrey C Glennon
Journal:  Neurosci Biobehav Rev       Date:  2007-01-23       Impact factor: 8.989

6.  Dopamine, time, and impulsivity in humans.

Authors:  Alex Pine; Tamara Shiner; Ben Seymour; Raymond J Dolan
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

7.  Modeling pharmacological clock and memory patterns of interval timing in a striatal beat-frequency model with realistic, noisy neurons.

Authors:  Sorinel A Oprisan; Catalin V Buhusi
Journal:  Front Integr Neurosci       Date:  2011-09-23

8.  Evaluating cognitive and motivational accounts of greater reinforcement effects among children with attention-deficit/hyperactivity disorder.

Authors:  Whitney D Fosco; Larry W Hawk; Keri S Rosch; Michelle G Bubnik
Journal:  Behav Brain Funct       Date:  2015-04-29       Impact factor: 3.759

9.  Monetary rewards modulate inhibitory control.

Authors:  Paula M Herrera; Mario Speranza; Adam Hampshire; Tristán A Bekinschtein
Journal:  Front Hum Neurosci       Date:  2014-05-12       Impact factor: 3.169

10.  The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex.

Authors:  Stephanie M McTighe; Sarah J Neal; Qian Lin; Zoë A Hughes; Daniel G Smith
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

View more
  11 in total

Review 1.  Neurobehavioral changes arising from early life dopamine signaling perturbations.

Authors:  Lorena B Areal; Randy D Blakely
Journal:  Neurochem Int       Date:  2020-04-20       Impact factor: 3.921

2.  Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D2 Autoreceptors Shapes the In Vivo Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559.

Authors:  Raajaram Gowrishankar; Paul J Gresch; Gwynne L Davis; Rania M Katamish; Justin R Riele; Adele M Stewart; Roxanne A Vaughan; Maureen K Hahn; Randy D Blakely
Journal:  J Neurosci       Date:  2018-05-08       Impact factor: 6.167

Review 3.  Review of rodent models of attention deficit hyperactivity disorder.

Authors:  Samantha L Regan; Michael T Williams; Charles V Vorhees
Journal:  Neurosci Biobehav Rev       Date:  2021-11-27       Impact factor: 8.989

4.  Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters.

Authors:  Adele Stewart; Felix P Mayer; Raajaram Gowrishankar; Gwynne L Davis; Lorena B Areal; Paul J Gresch; Rania M Katamish; Rodeania Peart; Samantha E Stilley; Keeley Spiess; Maximilian J Rabil; Faakhira A Diljohn; Angelica E Wiggins; Roxanne A Vaughan; Maureen K Hahn; Randy D Blakely
Journal:  Mol Psychiatry       Date:  2022-09-18       Impact factor: 13.437

Review 5.  Dysregulation of brain dopamine systems in major depressive disorder.

Authors:  Nella C Delva; Gregg D Stanwood
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-16

Review 6.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

7.  Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice.

Authors:  Adele Stewart; Gwynne L Davis; Paul J Gresch; Rania M Katamish; Rodeania Peart; Maximilian J Rabil; Raajaram Gowrishankar; F Ivy Carroll; Maureen K Hahn; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2018-12-21       Impact factor: 7.853

8.  Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter.

Authors:  Durairaj Ragu Varman; Mark A Subler; Jolene J Windle; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Behav Brain Res       Date:  2021-03-29       Impact factor: 3.352

9.  Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation.

Authors:  Vikas Navratna; Dilip K Tosh; Kenneth A Jacobson; Eric Gouaux
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

10.  Multi-domain cognitive assessment of male mice shows space radiation is not harmful to high-level cognition and actually improves pattern separation.

Authors:  Cody W Whoolery; Sanghee Yun; Ryan P Reynolds; Melanie J Lucero; Ivan Soler; Fionya H Tran; Naoki Ito; Rachel L Redfield; Devon R Richardson; Hung-Ying Shih; Phillip D Rivera; Benjamin P C Chen; Shari G Birnbaum; Ann M Stowe; Amelia J Eisch
Journal:  Sci Rep       Date:  2020-02-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.